Benzinga's Top #PreMarket Gainers

shares surged 20.44% to $3.30 in pre-market trading following the announcement of $14.5 million in component orders.

gained 8.97% to $3.16 in pre-market trading after surging 21.85% on Friday.

shares gained 5.58% to $2.08 in the pre-market trading session after the company reported positive results in blood of Phase 2 results of pacritinib in patients with myelofibrosis.

shares rose 2.71% to $17.06 in pre-market trading after the company received the FDA approval for WATCHMAN left atrial appendage closure device.

shares climbed 1.53% to $172.00 in pre-market trading.

and Salix have agreed on an amended $173 per share in cash deal.